3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput

HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.

Subsidie
€ 2.969.219
2022

Projectdetails

Introduction

Generating 3D in vitro functional tissues and organs in the millimeter scale remains an unmet dream of modern medicine. Irrespective of great efforts in the field of tissue engineering to design injectable/pipettable hydrogels or implantable/non-pipettable scaffolds for 3D cell growth, it is not yet possible to generate functional and personalized tissues with native-like structures and mature blood vessels.

Limitations of Current Materials

The main reason for this limitation is that current materials do not recapitulate the complexity and dynamics of the native cell environment. To create personalized human tissues, patient-derived induced pluripotent stem cells can differentiate into any cell type, but controlling stem cell expansion, differentiation, and organization inside the same 3D scaffold is not possible up to now. This control requires biomimetic and interactive materials beyond simple hydrogels.

Innovative Approach

HEARTBEAT will break with traditional ways to make 3D biomaterials by assembling and crosslinking a variety of unique pre-programmed, rod-shaped, and interactive microgels instead of molecular building blocks.

Main Aim

The main aim is to achieve macroporous, aligned, actuatable, and on-demand degradable constructs after automatically pipetting/mixing different microgels and cells, which is not possible with conventional hydrogels.

High-Throughput System

A compatible high-throughput system will be used to screen the innumerable combinations of design parameters to systematically study (stem)cell-material and cell-cell interactions to grow complex tissue.

Focus of the Project

In HEARTBEAT, I will focus on using the interactive bottom-up microgel assemblies to generate millimeter-scale vascularized beating heart tissues.

Research Goals

The project will elucidate how material properties, architectures, and actuation affect human heart tissue formation and vascularization and how the construct has to adapt to the growing tissue over time to provide the right extracellular environment.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.969.219
Totale projectbegroting€ 2.969.219

Tijdlijn

Startdatum1-10-2022
Einddatum30-9-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • DWI LEIBNIZ-INSTITUT FUR INTERAKTIVE MATERIALIEN EVpenvoerder
  • RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN
  • UNIVERSITAETSKLINIKUM AACHEN

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

€ 2.500.000
ERC Starting...

Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTs

G-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease.

€ 1.497.351
ERC Proof of...

SUPRAmolecular Hydrogel Driven Assembly of Designer Heart Tissues

The SUPRAHEART project aims to develop synthetic squaramide-based hydrogels for scalable engineered heart tissues, enhancing reproducibility for pharmaceutical testing and commercialization.

€ 150.000
ERC Starting...

Nanorobotic microgels to control stem cell fate

Developing innovative microgel technology with nanorobotics to enhance stem cell differentiation for improved cardiac regeneration in myocardial infarction patients.

€ 1.500.000
ERC Starting...

Surgical optogenetic bioprinting of engineered cardiac muscle

LIGHTHEART aims to revolutionize heart failure treatment by developing a surgical bioprinting tool that uses optogenetics to create engineered cardiac muscle directly at the patient's heart.

€ 1.499.705

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Next Generation 3D Tissue Models: Bio-Hybrid Hierarchical Organoid-Synthetic Tissues (Bio-HhOST) Comprised of Live and Artificial Cells.

Bio-HhOST aims to create bio-hybrid materials with living and artificial cells for dynamic communication, enhancing tissue modeling and reducing animal use in drug research.

€ 1.225.468
EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

€ 4.475.946
EIC Transition

Bringing 3D cardiac tissues to high throughput for drug discovery screens

Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.

€ 1.457.500
EIC Pathfinder

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

€ 2.999.625
EIC Pathfinder

building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans

THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.

€ 3.994.150